Blood test for early Alzheimer’s detection

Researchers funded by the NIH have developed a method to detect toxic Aβ oligomers in patients’ blood, showing potential for early detection of Alzheimer’s disease. Tested on nearly 400 human blood samples, this method offers a way to intervene before significant brain damage occurs, and could also be adapted to detect other neurodegenerative diseases like Parkinson’s. (Source: NIH)

Share the Post:

Related Posts

Stroke experts to test emerging nerve stimulation treatment

A new stroke therapy that delivers electrical pulses to the brain via a portable device will be tested in a pioneering trial to improve arm recovery after stroke. Led by researchers from Sheffield Teaching Hospitals NHS Foundation Trust and the University of Sheffield, this trial aims to determine if transcutaneous vagus nerve stimulation can enhance hand and arm strength during rehabilitation therapy for stroke survivors. (Source: PharmaTimes)

Read More

FDA approval could shape liver disease treatment landscape

The FDA has approved Rezdiffra (resmetirom) for the treatment of noncirrhotic non-alcoholic steatohepatitis (NASH), also known as fatty liver disease. This approval, under the FDA’s Accelerated Approval program, is based on Phase III data showing Rezdiffra’s efficacy in reducing fat accumulating in the liver. (Source: European Pharmaceutical Review)

Read More